SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001013762-14-001148
Filing Date
2014-10-03
Accepted
2014-10-03 16:57:59
Documents
7
Period of Report
2014-09-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 DELMAR PHARMACEUTICALS, INC. FORM 8-K form8k.htm 8-K 19527
2 EX 3.1 CERTIFICATE OF DESIGNATION OF SERIES A PREFERRED STOCK ex31.htm EX-3.1 4252
3 EXHIBIT 10.1 EXCHANGE AGREEMENT ex101.htm EX-10.1 14109
4 GRAPHIC ex31_1.jpg GRAPHIC 201282
5 GRAPHIC ex31_2.jpg GRAPHIC 367407
6 GRAPHIC ex31_3.jpg GRAPHIC 340125
7 GRAPHIC ex31_4.jpg GRAPHIC 50840
  Complete submission text file 0001013762-14-001148.txt   1361985
Mailing Address SUITE 720-999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720-999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (604) 629-5989
DelMar Pharmaceuticals, Inc. (Filer) CIK: 0001498382 (see all company filings)

IRS No.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-54801 | Film No.: 141140404
SIC: 2834 Pharmaceutical Preparations